Susunod

Auto-play

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 Mga view • 07/14/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play